GuruTrack
EW

EW

EDWARDS LIFESCIENCES CORP

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary
EDWARDS LIFESCIENCES CORP (EW) is held as common stock by 8 tracked hedge-fund managers, with a combined reported value of ~$912.88M; the largest are Ken Griffin, Izzy Englander, Steven Cohen. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 5 added, 3 trimmed, 1 closed. 20 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Mixed
Common-stock holders84 also report options
Congress trades20
Price$86.83vs quarter-end-4.01%
Sectors1
This quarter's moves
New0
Added5
Trimmed / sold4
Top holderKen Griffin

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Davidson KempnerAdd
Value $28.72M0.7% of portfolio317,5002026 Q2

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—
Value $19.92M— of portfolio220,2002026 Q2
Izzy EnglanderPUT—
Value $12.18M— of portfolio134,6002026 Q2
Ken GriffinPUT—
Value $4.84M— of portfolio53,5002026 Q2
Izzy EnglanderCALL—
Value $4.36M— of portfolio48,2002026 Q2
Paul Tudor JonesCALL—
Value $2.79M— of portfolio30,8002026 Q2
Steven CohenCALL—
Value $533.7K— of portfolio5,9002026 Q2
Steven CohenPUT—
Value $45.2K— of portfolio5002026 Q2

Insider Trading

Officers · directors · Form 4
Open-market purchases and sales (P/S)11

  • Daniel J. Lippis

    CVP, TAVR

    Sell$54.2K
    619 @ $87.51Traded 2026-09-11Filed 2026-09-11

  • Andrew M. Dahl

    SVP, Corporate Controller

    Sell$49.5K
    544 @ $91.06Traded 2026-08-31Filed 2026-08-31

  • Annette Bruls

    CVP, EMEACLA

    Sell$237.9K
    2,644 @ $89.98Traded 2026-08-28Filed 2026-08-28

  • Wayne Markowitz

    CVP, JAPAC

    Sell$113.4K
    1,240 @ $91.47Traded 2026-08-26Filed 2026-08-26

  • Daveen Chopra

    CVP, TMTT, Surgical & IHFM

    Sell$2.79M
    30,646 @ $90.99Traded 2026-08-26Filed 2026-08-26

  • Daveen Chopra

    CVP, TMTT, Surgical & IHFM

    Sell$105.9K
    1,154 @ $91.76Traded 2026-08-26Filed 2026-08-26

  • Daniel J. Lippis

    CVP, TAVR

    Sell$57.0K
    619 @ $92.03Traded 2026-08-11Filed 2026-08-11

  • Wayne Markowitz

    CVP, JAPAC

    Sell$12.6K
    146 @ $86.03Traded 2026-07-30Filed 2026-07-30

  • Wayne Markowitz

    CVP, JAPAC

    Sell$819.0K
    9,628 @ $85.06Traded 2026-07-28Filed 2026-07-28

  • Bernard J Zovighian

    CEO

    Sell$245.1K
    2,921 @ $83.93Traded 2026-07-27Filed 2026-07-27

  • Daniel J. Lippis

    CVP, TAVR

    Sell$56.8K
    619 @ $91.70Traded 2026-07-10Filed 2026-07-10

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.